TY - JOUR
T1 - Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
AU - Swarup, Vivek
AU - Hinz, Flora I
AU - Rexach, Jessica E
AU - Noguchi, Ken-Ichi
AU - Toyoshiba, Hiroyoshi
AU - Oda, Akira
AU - Hirai, Keisuke
AU - Sarkar, Arjun
AU - Seyfried, Nicholas T
AU - Cheng, Chialin
AU - Haggarty, Stephen J
AU - Grossman, Murray
AU - Van Deerlin, Vivianna M
AU - Trojanowski, John Q
AU - Lah, James J
AU - Levey, Allan I
AU - Kondou, Shinichi
AU - Geschwind, Daniel H
AU - International Frontotemporal Dementia Genomics Consortium
A2 - Hjermind, Lena Elisabeth
A2 - Nielsen, Jørgen Erik
PY - 2019/1
Y1 - 2019/1
N2 - Identifying the mechanisms through which genetic risk causes dementia is an imperative for new therapeutic development. Here, we apply a multistage, systems biology approach to elucidate the disease mechanisms in frontotemporal dementia. We identify two gene coexpression modules that are preserved in mice harboring mutations in MAPT, GRN and other dementia mutations on diverse genetic backgrounds. We bridge the species divide via integration with proteomic and transcriptomic data from the human brain to identify evolutionarily conserved, disease-relevant networks. We find that overexpression of miR-203, a hub of a putative regulatory microRNA (miRNA) module, recapitulates mRNA coexpression patterns associated with disease state and induces neuronal cell death, establishing this miRNA as a regulator of neurodegeneration. Using a database of drug-mediated gene expression changes, we identify small molecules that can normalize the disease-associated modules and validate this experimentally. Our results highlight the utility of an integrative, cross-species network approach to drug discovery.
AB - Identifying the mechanisms through which genetic risk causes dementia is an imperative for new therapeutic development. Here, we apply a multistage, systems biology approach to elucidate the disease mechanisms in frontotemporal dementia. We identify two gene coexpression modules that are preserved in mice harboring mutations in MAPT, GRN and other dementia mutations on diverse genetic backgrounds. We bridge the species divide via integration with proteomic and transcriptomic data from the human brain to identify evolutionarily conserved, disease-relevant networks. We find that overexpression of miR-203, a hub of a putative regulatory microRNA (miRNA) module, recapitulates mRNA coexpression patterns associated with disease state and induces neuronal cell death, establishing this miRNA as a regulator of neurodegeneration. Using a database of drug-mediated gene expression changes, we identify small molecules that can normalize the disease-associated modules and validate this experimentally. Our results highlight the utility of an integrative, cross-species network approach to drug discovery.
UR - http://www.scopus.com/inward/record.url?scp=85058010718&partnerID=8YFLogxK
U2 - 10.1038/s41591-018-0223-3
DO - 10.1038/s41591-018-0223-3
M3 - Journal article
C2 - 30510257
SN - 1078-8956
VL - 25
SP - 152
EP - 164
JO - Nature Medicine
JF - Nature Medicine
IS - 1
ER -